Image
12.10.2023
Duo who took on Tough Mudder challenge for us celebrate fundraising su...
Two colleagues who successfully undertook a gruelling Tough Mudder challenge are celebrating raising fund...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more